Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by francois21on Apr 06, 2014 11:53am
343 Views
Post# 22417478

RE:RE:No buyout and partnership is most likely outcome

RE:RE:No buyout and partnership is most likely outcomeWhat I would like to see isn't a buyout or a JV. Why not a huge financing for $ 100M and simply go alone. PBI-4050 have a potentiel in a few billions dollars market overall. What would represent a 10-15% dilution if we keep 100% of the revenues? This could also provide an opportunity to devellop additionnal plasma proteins faster than expected.
Bullboard Posts